GGrantIndex
Sort

46,585 grants matching heart failure

MMP Responsive Nanoparticles for Treating Acute Myocardial Infarction

$387,500
Karen L Christman · University Of California, San Diego · R01 · FY2017 · HL

Relaxin Signaling in Post-MI Cardiac Inflammation, Adverse Remodeling and Failure

$387,500
Fadi N Salloum · Virginia Commonwealth University · R01 · FY2018 · HL

Signaling Pathways in Dilated Cardiomyopathy

$387,500
Stephan Lange · University Of California, San Diego · R01 · FY2018 · HL

Targeting GRK2 (BARK1) in Heart Failure

$387,500
Walter J Koch · Temple Univ Of The Commonwealth · R37 · FY2017 · HL

QUANTITATIVE ANALYSIS OF LEFT VENTRICULOPLASTY--CHF

$387,500
Mark B Ratcliffe · Northern California Institute/Res/Edu · R01 · FY2011 · HL

Therapeutic Targets for Chronic Allograft Rejection

$387,500
D. Keith Bishop · University Of Michigan At Ann Arbor · R01 · FY2011 · HL

Cytosolic Calcium Sweeper in Cardiac Myocytes

$387,500
Hector H Valdivia · University Of Michigan At Ann Arbor · R01 · FY2016 · HL

MCL-1 is a critical regulator of mitochondrial dynamics and function in myocytes

$387,500
Asa B. Gustafsson · University Of California, San Diego · R01 · FY2017 · HL

Effects of recombinant human leptin in nonalcoholic fatty liver disease (NAFLD)

$387,500
Elif Arioglu Oral · University Of Michigan At Ann Arbor · R01 · FY2011 · DK

The role of Nexilin in cardiomyocyte and cardiomyopathy

$387,500
Ju Chen · University Of California, San Diego · R01 · FY2020 · HL

Sphingosine 1-phosphate and cardioprotection

$387,500
Joel S Karliner · Northern California Institute/Res/Edu · R01 · FY2011 · HL

MMP Responsive Nanoparticles for Treating Acute Myocardial Infarction

$387,500
Karen L Christman · University Of California, San Diego · R01 · FY2018 · HL

MCL-1 is a critical regulator of mitochondrial dynamics and function in myocytes

$387,500
Asa B. Gustafsson · University Of California, San Diego · R01 · FY2019 · HL

Nox4 and Cardiac Fibrosis

$387,500
Dan Sorescu · Emory University · R01 · FY2011 · HL

Hydrogen sulfide attenuates heart failure through Nrf2-mediated signaling

$387,500
John Winter Calvert · Emory University · R01 · FY2011 · HL

Limiting Pathological Calcium Induced Calcium Release in Heart

$387,500
Michael Fill · Rush University Medical Center · R01 · FY2017 · HL

Myeloid reprogramming in cardiac protection by aldosterone antagonists

$387,500
Richard M Mortensen · University Of Michigan At Ann Arbor · R01 · FY2016 · HL

Pathophysiological Regulation of Atrial Myocyte Excitation-Contraction Coupling and Calcium Signaling

$387,500
Lothar A Blatter · Rush University Medical Center · R01 · FY2020 · HL

Measuring Left Ventricular Dyssynchrony from ECG-gated Myocardial Perfusion SPECT

$387,500
Ji Chen · Emory University · R01 · FY2011 · HL

Limiting Pathological Calcium Induced Calcium Release in Heart

$387,500
Michael Fill · Rush University Medical Center · R01 · FY2019 · HL

Signaling Pathways in Dilated Cardiomyopathy

$387,500
Stephan Lange · University Of California, San Diego · R01 · FY2015 · HL

Aldosterone and Sodium Regulation in Postural Tachycardia Syndrome

$387,500
Satish R Raj · Vanderbilt University · R01 · FY2010 · HL

MMP Responsive Nanoparticles for Treating Acute Myocardial Infarction

$387,500
Karen L Christman · University Of California, San Diego · R01 · FY2020 · HL

QUANTITATIVE ANALYSIS OF LEFT VENTRICULOPLASTY--CHF

$387,500
Mark B Ratcliffe · Northern California Institute/Res/Edu · R01 · FY2010 · HL

Pathophysiological Regulation of Atrial Alternans and Atrial Fibrillation

$387,500
Lothar A Blatter · Rush University Medical Center · R01 · FY2020 · HL